Mirabella Financial Services LLP Clovis Oncology, Inc. Transaction History

Mirabella Financial Services LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.63 - $2.96 $11,088 - $52,096	-17,600 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.43 - $3.14 $25,168 - $55,264	17,600 New	17,600 $36,000
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $106,058 - $164,608	-25,680 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $123,777 - $198,249	25,680 New	25,680 $150,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.